Inventor · disambiguated record
Edward Tuddenham
Also filed as: TUDDENHAM EDWARD
12 granted patents·5 pending applications·95 citations·filing 2010–2025
91Inventor score
Files withUCL BUSINESS PLC6BIOMARIN PHARM INC5UCL BUSINESS LTD4CANTAB BIOPHARMACEUTICALS PATENTS LTD1NATHWANI AMIT1
Top patents by PatentIndex Score
17 records- 0196US9504762B2Adeno-associated virus factor VIII vectorsBIOMARIN PHARM INC·Filed 2014·Granted Nov 29, 2016·28 cites·9 claims
- 0296US9447168B2Nucleic acid molecules encoding modified factor VIII proteinsUCL BUSINESS PLC·Filed 2013·Granted Sep 20, 2016·18 cites·8 claims
- 0391US9764045B2Optimised coding sequence and promoterUCL BUSINESS PLC·Filed 2015·Granted Sep 19, 2017·14 cites·3 claims
- 0490US10124041B2Methods of delivering factor VIII encoding nucleic acid sequencesUCL BUSINESS PLC·Filed 2016·Granted Nov 13, 2018·4 cites·8 claims
- 0588US10709796B2Optimised coding sequence and promoterUCL BUSINESS PLC·Filed 2017·Granted Jul 14, 2020·4 cites·6 claims
- 0688US9393323B2Optimised coding sequence and promoterNATHWANI AMIT·Filed 2010·Granted Jul 19, 2016·22 cites·8 claims
- 0788US2025108093A1Factor VIII SequencesUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 0887US10792336B2Method of treating hemophilia AUCL BUSINESS PLC·Filed 2018·Granted Oct 6, 2020·2 cites·12 claims
- 0985US10463718B2Adeno-associated virus factor VIII vectorsBIOMARIN PHARM INC·Filed 2016·Granted Nov 5, 2019·3 cites·10 claims
- 1083US12239692B2Adeno-associated virus factor VIII vectorsBIOMARIN PHARM INC·Filed 2022·Granted Mar 4, 2025·0 cites·5 claims
- 1180US2023241180A1Factor VIII SequencesUCL BUSINESS LTD·Filed 2022·Application pending·0 cites
- 1276US11406690B2Adeno-associated virus factor VIII vectorsBIOMARIN PHARM INC·Filed 2019·Granted Aug 9, 2022·0 cites·5 claims
- 1376US2025332224A1Adeno-Associated Virus Factor VIII VectorsBIOMARIN PHARM INC·Filed 2025·Application pending·0 cites
- 1474US11419920B2Factor VIII sequencesUCL BUSINESS LTD·Filed 2020·Granted Aug 23, 2022·0 cites·9 claims
- 1571US12257319B2Optimised coding sequence and promoterUCL BUSINESS LTD·Filed 2020·Granted Mar 25, 2025·0 cites·20 claims
- 1662US2018161403A1Adeno-associated virus factor viii vectorsUCL BUSINESS PLC·Filed 2017·Application pending·0 cites
- 1747US2025064738A1Modified colloidal particles for use in the treatment of haemophilia aCANTAB BIOPHARMACEUTICALS PATENTS LTD·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →